South Korea · Delayed Price · Currency is KRW IntroMedic Statistics
Total Valuation
IntroMedic has a market cap or net worth of KRW 6.45 billion. The enterprise value is 7.54 billion.
| Market Cap | 6.45B |
| Enterprise Value | 7.54B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
IntroMedic has 43.00 million shares outstanding. The number of shares has increased by 5.88% in one year.
| Current Share Class | 43.00M |
| Shares Outstanding | 43.00M |
| Shares Change (YoY) | +5.88% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.24% |
| Owned by Institutions (%) | n/a |
| Float | 38.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| PB Ratio | 1.46 |
| P/TBV Ratio | 1.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.44 |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -26.43 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.50.
| Current Ratio | 2.00 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.81 |
| Interest Coverage | -12.04 |
Financial Efficiency
Return on equity (ROE) is -24.67% and return on invested capital (ROIC) is -32.20%.
| Return on Equity (ROE) | -24.67% |
| Return on Assets (ROA) | -11.04% |
| Return on Invested Capital (ROIC) | -32.20% |
| Return on Capital Employed (ROCE) | -35.16% |
| Weighted Average Cost of Capital (WACC) | 1.85% |
| Revenue Per Employee | 170.45M |
| Profits Per Employee | -23.46M |
| Employee Count | 59 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 0.98 |
Taxes
| Income Tax | -1.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.66 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 10,180,020 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IntroMedic had revenue of KRW 10.06 billion and -1.38 billion in losses. Loss per share was -32.19.
| Revenue | 10.06B |
| Gross Profit | 6.38B |
| Operating Income | -1.83B |
| Pretax Income | -1.32B |
| Net Income | -1.38B |
| EBITDA | -1.26B |
| EBIT | -1.83B |
| Loss Per Share | -32.19 |
Balance Sheet
The company has 1.02 billion in cash and 2.22 billion in debt, with a net cash position of -1.20 billion or -27.96 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 2.22B |
| Net Cash | -1.20B |
| Net Cash Per Share | -27.96 |
| Equity (Book Value) | 4.43B |
| Book Value Per Share | 105.80 |
| Working Capital | 3.36B |
Cash Flow
In the last 12 months, operating cash flow was -255.06 million and capital expenditures -29.99 million, giving a free cash flow of -285.05 million.
| Operating Cash Flow | -255.06M |
| Capital Expenditures | -29.99M |
| Free Cash Flow | -285.05M |
| FCF Per Share | -6.63 |
Margins
Gross margin is 63.43%, with operating and profit margins of -18.20% and -13.76%.
| Gross Margin | 63.43% |
| Operating Margin | -18.20% |
| Pretax Margin | -13.09% |
| Profit Margin | -13.76% |
| EBITDA Margin | -12.53% |
| EBIT Margin | -18.20% |
| FCF Margin | n/a |
Dividends & Yields
IntroMedic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.88% |
| Shareholder Yield | -5.88% |
| Earnings Yield | -21.46% |
| FCF Yield | -4.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 10, 2018. It was a forward split with a ratio of 2.
| Last Split Date | May 10, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |